EPIRUS Biopharmaceuticals Volatility

EPIRUS Biopharmaceuticals Pink Sheet Volatility Analysis

EPIRUS Biopharmaceutica Projected Return Density Against Market

Assuming the 90 days horizon EPIRUS Biopharmaceutica has a beta that is very close to zero suggesting the returns on DOW JONES INDUSTRIAL and EPIRUS Biopharmaceutica do not appear to be sensible. It does not look like EPIRUS Biopharmaceutica's alpha can have any bearing on the current valuation. EPIRUS Biopharmaceutica's volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how epirus pink sheet's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives an EPIRUS Biopharmaceutica Price Volatility?

Several factors can influence a pink sheet's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

EPIRUS Biopharmaceutica Pink Sheet Return Volatility

EPIRUS Biopharmaceutica historical daily return volatility represents how much of EPIRUS Biopharmaceutica pink sheet's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The enterprise shows 0.0% volatility of returns over 90 . By contrast, Dow Jones Industrial accepts 0.7444% volatility on return distribution over the 90 days horizon.

Volatility is a rate at which the price of EPIRUS Biopharmaceutica or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of EPIRUS Biopharmaceutica may increase or decrease. In other words, similar to EPIRUS's beta indicator, it measures the risk of EPIRUS Biopharmaceutica and helps estimate the fluctuations that may happen in a short period of time. So if prices of EPIRUS Biopharmaceutica fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.

EPIRUS Biopharmaceutica's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on EPIRUS Pink Sheet over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much EPIRUS Biopharmaceutica's price varies over time.

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.

The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against EPIRUS Biopharmaceutica as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. EPIRUS Biopharmaceutica's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, EPIRUS Biopharmaceutica's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to EPIRUS Biopharmaceuticals.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

If you are still planning to invest in EPIRUS Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EPIRUS Biopharmaceutica's history and understand the potential risks before investing.